38.Dempsey, J.A.et al. (2010) Pathophysiology ofsleep apnea.Physiol. Rev.90, 47–11239.Weese-Mayer, D.E.et al. (2010) An official ATSclinical policy statement: congenital centralhypoventilation syndrome: genetic basis, diagnosis,and management.Am. J. Respir. Crit. Care Med.181, 626–64440.Garcia, A.J., IIIet al. (2013) The physiologicaldeterminants of sudden infant death syndrome.Respir. Physiol Neurobiol.189, 288–30041.Carroll, M.S.et al. (2014) Residual chemosensitivityto ventilatory challenges in genotyped congenitalcentral hypoventilation syndrome.J. Appl. Physiol.(1985)116, 439–45042.Amiel, J.et al. (2003) Polyalanine expansion andframeshift mutations of the paired-like homeoboxgene PHOX2B in congenital central hypoventilationsyndrome.Nat. Genet.33, 459–46143.Goridis, C.et al. (2010) Phox2b, congenitalcentral hypoventilation syndrome and thecontrol of respiration.Semin. Cell Dev. Biol.21,814–82244.Dubreuil, V.et al. (2008) A human mutation inPhox2b causes lack of CO2chemosensitivity, fatalcentral apnoea and specific loss of parafacialneurons.Proc. Natl Acad. Sci. U. S. A.105, 1067–107245.Rudzinski, E. and Kapur, R.P. (2010) PHOX2Bimmunolocalization of the candidate humanretrotrapezoid nucleus.Pediatr. Dev. Pathol.13,291–29946.Levy, J.et al. (2019) Tridimensional mapping ofPhox2b expressing neurons in the brainstem ofadultMacaca fascicularisand identification of theretrotrapezoid nucleus.J. Comp. Neurol.527,2875–288447.Perez, I.A. and Keens, T.G. (2013) Peripheralchemoreceptors in congenital centralhypoventilation syndrome.Respir. Physiol.